HPV Screening (Human Papilloma Virus)

Screening for Human Papilloma Virus in Urine and Pap Smear.A Comparative Study.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02613611

Acronym

HPV

Enrollment

500

Registered

2015-11-24

Start date

2015-11-30

Completion date

2016-03-31

Last updated

2015-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV Testing

Brief summary

Examination of cervical &urine samples for HPV

Detailed description

500 females attending colposcopy kasrelaini unit are included. History including age and parity is taken.urine samples are taken. Colposcopy will be done. Pap smear will be taken and sent for pathology.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

* all females attending colposcopy kasrelaini unit aging 18\_45 years

Exclusion criteria

* females with known cervical cancer * females less than 18 or more than 45

Design outcomes

Primary

Measure	Time frame
Number of patients with positive urine test for HPV Number of patients with positive pap smear.	3 months

Outcome results